Scalable OEM Immunodiagnostic Solutions: Partnering with Hotgen Biotech to Build a Global IVD Manufacturing Ecosystem

What is OEM Collaboration for Immunoassay Analyzers?

Definition: OEM collaboration for immunoassay analyzers is a B2B strategic cooperation model where professionally qualified medical diagnostic manufacturing companies are responsible for the design and production of diagnostic hardware, software, and reagents, while partners handle branding, regulatory certification, and global distribution.

In the fiercely competitive in vitro diagnostics (IVD) market, developing proprietary diagnostic infrastructure from scratch requires significant funding and years of R&D. By establishing OEM or ODM partnerships, global healthcare brands can bypass these high entry barriers. This collaboration allows companies to directly leverage clinically validated, regulatory-compliant testing hardware, thereby concentrating core resources on market expansion and localized customer service. According to the, maintaining strict quality control during this technology transfer process is crucial for ensuring patient safety and clinical accuracy.

Hotgen Biotech's Advanced Immunoassay Platforms: From POCT to High-Throughput Systems

Definition: Immunoassay platforms refer to a spectrum of automated laboratory instruments used for the detection and quantitative analysis of specific biomarkers in clinical samples, ranging from distributed point-of-care testing (POCT) devices to centralized high-throughput systems.

Hotgen Biotech offers a rich and highly scalable product portfolio ofdesigned to meet the needs of various laboratory levels. From high-precision up-conversion luminescence POCT devices (UPT series) to compact single-sample fully automated chemiluminescence analyzers (MQ60 series), we perfectly cover the decentralized scenario's point-of-care testing needs. For centralized, high-sample-volume standard laboratories, our fully automated chemiluminescence pipeline platform (C800 series) offers excellent detection throughput.

Our mature test menu includes over 100 parameters, comprehensively covering key disease areas including thyroid function, reproductive hormones, cardiovascular disease, inflammation and infection, tumor markers, liver disease testing, and drugs of abuse (DOA).

Product Matrix Comparison for OEM Procurement

Global Regulatory Compliance: Overcoming IVDR and NMPA Barriers with OEM Expertise

Definition: Regulatory compliance in the IVD industry refers to the manufacturing of diagnostic hardware and reagents that must strictly align with international legal frameworks to ensure clinical effectiveness, diagnostic sensitivity, and traceability throughout the production process.

In the commercialization process of diagnostic equipment, crossing international medical regulations is one of the highest barriers. Hotgen Biotech is committed to removing this obstacle for OEM partners. Established in 2005 and listed on the Shanghai Stock Exchange's STAR Market in September 2019 (stock code: 688068), Hotgen Biotech possesses institutional-level financial transparency and standardized operational strength.

We hold over 600 overseas registration certificates, including key certifications from China's NMPA, Germany's BfArM, and the UK's MHRA. Most notably, we have obtained over 90 EU CE IVDR certificates, fully complying with the stringent requirements of the. This solid regulatory foundation can help our OEM partners significantly shorten the overseas registration process and achieve rapid product market entry.

End-to-End OEM/ODM Services: Accelerate Your Diagnostic Product Market Entry

Definition: End-to-End OEM/ODM services in the diagnostic field cover the entire product lifecycle, including customized industrial design, software localization, reagent adaptation, technology transfer, and international logistics management.

At Hotgen Biotech, we not only provide hardware but also develop solutions with you. Our innovation incubation platform, the Institute of Future Technology, is dedicated to translating cutting-edge scientific discoveries into commercial outcomes. This platform continuously infuses our OEM pipeline with a steady stream of innovative momentum (e.g., advanced antibody design and biotechnology applications).

We have established overseas subsidiaries and offices in core markets such as Europe, India, and the Americas. This mature global footprint ensures OEM partners can receive instant localized technical support, seamless technology transfer, and robust supply chain assurance. Whether you need customized instrument housing design, specific localized software interfaces, or exclusive reagent packaging, our engineering team can provide high-precision, scalable delivery. Visit ourcorporate page to learn more about our international infrastructure layout.

Why Choose Hotgen Biotech as Your Strategic Immunoassay Analyzers Partner?

Definition: Strategic OEM sourcing for immunoassay analyzers is an agile business model that allows global healthcare brands to leverage the R&D infrastructure and regulatory access credentials of established manufacturers to rapidly expand their clinical chemistry and immunodiagnostic product portfolios.

Choosing to partner with Hotgen Biotech means working alongside an industry pioneer committed to the mission of "developing biotechnology to benefit human health." We have built a complete industrial chain from professional diagnostics to innovative drugs, ensuring long-term reagent stability, highly cost-competitive instrument manufacturing, and continuous expansion of the test menu. By combining our lean manufacturing capabilities with your brand assets, we can deliver high-precision diagnostic tools to every community worldwide that urgently needs medical services.

If you are ready to quickly expand your diagnostic product portfolio with "zero R&D friction," please visit ourportal to learn technical details and start business negotiations.

Frequently Asked Questions (FAQ)

1. What types of immunoassay analyzers can Hotgen Biotech provide for OEM collaboration?

Hotgen Biotech offers a full spectrum of analyzers for OEM collaboration, including the UPT series (up-conversion luminescence POCT), MQ60 series (compact single-sample fully automated chemiluminescence analyzers), and C800 series (high-throughput, centralized fully automated chemiluminescence platforms).

2. Can we customize specific reagent menus or open the system to match our own reagents?

Yes. Our OEM/ODM services are highly flexible. We can customize the existing menu of over 130 parameters (including thyroid, myocardial, and tumor markers) according to your brand requirements or jointly debug instruments to match your proprietary reagent protocols based on specific project needs.

3. How does Hotgen Biotech support the EU CE IVDR compliance of OEM products?

Hotgen Biotech is an industry leader in regulatory compliance, currently holding over 90 EU CE IVDR certificates. In OEM collaborations, we provide complete technical documentation, clinical evaluation reports, and manufacturing data that comply withand EU IVDR standards, helping your brand quickly clear regulatory hurdles.

4. How long does a typical OEM development project for an immunoassay analyzer take?

The project timeline depends on the level of customization. Standard branding (involving logo adjustments, VI screen printing, and packaging changes) can usually be completed within a few months; if deep ODM customization is involved (such as housing structure modifications, specific software communication protocol development), it will be managed in structured milestone phases, resulting in a relatively longer timeline.

5. Are Hotgen Biotech's production facilities internationally certified?

Yes. Hotgen Biotech has modern production facilities that operate strictly according to international medical device quality management systems, including ISO 13485 certification, ensuring that every immunoassay analyzer meets the highest global clinical safety standards.

6. How do you provide after-sales and technical support services for international OEM customers?

We provide comprehensive technology transfer training for your engineering team. Additionally, our global subsidiaries and regional offices in Europe, India, and the Americas offer secondary technical support, spare parts supply, and emergency troubleshooting to ensure smooth and worry-free localized operations.

Conclusion

Choosing the right OEM partner for immunoassay analyzers is a key decision directly related to your brand's clinical reputation and market penetration speed. Hotgen Biotech combines over 20 years of IVD core strength, the robust strength of a STAR Market-listed company (688068), outstanding international access qualifications (90+ CE IVDR certificates), and over 130 test parameters to create an unparalleled manufacturing partnership for you. Let us bear the complex R&D and manufacturing compliance risks, helping your brand lighten its load, expand its global footprint, and benefit human health.

References

1. FDA IVD guidelines

https://www.fda.gov/medical-devices/vitro-diagnostics/

2. European Commission IVDR Framework

https://health.ec.europa.eu/medical-devices-sector/new-regulations_en

3. WHO Guidance on Diagnostic Prequalification

https://www.who.int/teams/regulation-prequalification